DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zenser, T. V.
Right arrow Articles by Davis, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zenser, T. V.
Right arrow Articles by Davis, B. B.

Vol. 27, Issue 9, 1064-1067, September 1999

Human and Escherichia coli beta -Glucuronidase Hydrolysis of Glucuronide Conjugates of Benzidine and 4-Aminobiphenyl, and their Hydroxy Metabolites

Terry V. Zenser, Vijaya M. Lakshmi, and Bernard B. Davis

Veterans Administration Medical Center and Edward A. Doisy Department of Biochemistry and Division of Geriatric Medicine, St. Louis University School of Medicine, St. Louis, Missouri

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Individuals exposed to carcinogenic aromatic amines excrete arylamine N- and O-glucuronide metabolites. This study assessed the susceptibility of selected glucuronides to hydrolysis by human and Escherichia coli beta -glucuronidase. N- or O-glucuronides were prepared with the following aglycones: benzidine, N-acetylbenzidine, N'-hydroxy-N-acetylbenzidine, N-hydroxy-N-acetylbenzidine, N-hydroxy-N,N'-diacetylbenzidine, 3-hydroxy-N,N'-diacetylbenzidine, 3-hydroxy-benzidine, 4-aminobiphenyl, N-hydroxy-4-aminobiphenyl, and N-hydroxy-N-acetyl-4-aminobiphenyl. The 3H- and 14C-labeled glucuronides were prepared with human or rat liver microsomes using UDP-glucuronic acid as cosubstrate. Each of the 10 glucuronides (6-12 µM) was incubated at pH 5.5 or 7.0 with either human recombinant (pure) or E. coli (commercial preparation) beta -glucuronidase for 30 min at 37°C. Hydrolysis was measured by HPLC. Reaction conditions were optimized, using the O-glucuronide of N-hydroxy-N,N'-diacetylbenzidine. Both enzymes preferentially hydrolyzed O-glucuronides over N-glucuronides and distinguished between structural isomers. With E. coli beta -glucuronidase at pH 7.0, selectivity was demonstrated by the complete hydrolysis of N-hydroxy-N-acetyl-4-aminobiphenyl O-glucuronide in the presence of N-acetylbenzidine N-glucuronide, which was not hydrolyzed. Metabolism by both enzymes was completely inhibited by the specific beta -glucuronidase inhibitor saccharic acid-1,4-lactone (0.5 mM). The concentration of human beta -glucuronidase necessary to achieve significant hydrolysis of glucuronides was substantially more than the amount of enzyme reported previously to be present in urine under either normal or pathological conditions. The bacterial enzyme may hydrolyze O-glucuronides, but not N-glucuronides, in urine at neutral pH. Thus, the nonenzymatic hydrolysis of N-glucuronides by acidic urine is likely a more important source of free amine than enzymatic hydrolysis.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Aromatic amines cause bladder cancer in humans. Exposure to aromatic amines can occur in chemical, dye, and rubber industries (Doll and Peto, 1981), from cigarette smoke (Ross et al., 1988), and from motor vehicle exhaust (Guerin and Buchanan, 1988). Proposed mechanisms of aromatic amine initiation of bladder cancer are thought to involve multiple organs (i.e., liver, kidney, and bladder) and pathways (i.e., N- and O-oxidation, peroxidation, N- and O-acetylation, and glucuronidation; Kadlubar et al., 1977; Lakshmi et al., 1998). A recent study has demonstrated the presence of N-glucuronides of benzidine and N-acetylbenzidine in urine from workers exposed to benzidine (Rothman et al., 1997). Urine has been proposed to play an important role in initiation of carcinogenesis. Considering the routes of possible aromatic amine exposure and the site of tumor formation, urine serves as a means of transporting aromatic amines and their metabolites to the bladder lumen. In addition, acidic urine hydrolyzes N-glucuronides of aromatic amines (Babu et al., 1992, 1993). Urine also contains beta -glucuronidase, which can hydrolyze glucuronide metabolites. The role of beta -glucuronidase in aromatic amine bladder carcinogenesis is not known.

Human beta -glucuronidase is mainly found in the lysosomes and microsomes of normal tissues, with plasma levels of enzyme quite low. beta -Glucuronidase is normally excreted in urine with cells of the urinary tract the primary source of enzyme (Wachstein, 1955; Bank and Bailine, 1965). Increased urinary levels of enzyme are observed in conditions that affect the urinary tract, such as acute renal necrosis, active pyelonephritis, and cancer of the kidney and bladder (Gonick et al., 1973). The enzyme has a characteristic acidic pH optimum. In contrast, Escherichia coli beta -glucuronidase has a much higher pH optimum (Ho and Ho, 1985). E. coli beta -glucuronidase may also be present in urine due to urinary tract infection. The susceptibility of N- and O-glucuronides of aromatic amines to hydrolysis by beta -glucuronidase has not been rigorously tested. This study used E. coli beta -glucuronidase and pure human recombinant beta -glucuronidase to assess metabolism of 10 N- and O-glucuronides of benzidine and 4-aminobiphenyl and their hydroxy metabolites. The experiments demonstrate selectivity in hydrolysis of these glucuronides by both beta -glucuronidases.


    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The following compounds were used as substrates for the synthesis of glucuronides: benzidine, N-acetylbenzidine, N'-hydroxy-N-acetylbenzidine, N-hydroxy-N-acetylbenzidine, N-hydroxy-N,N'-diacetylbenzidine, 3-hydroxy-N,N'-diacetylbenzidine, 3-hydroxy-benzidine, 4-aminobiphenyl, N-hydroxy-4-aminobiphenyl, and N-hydroxy-N-acetyl-4-aminobiphenyl. These compounds were purchased from Sigma Chemical Co. (St. Louis, MO), Midwest Research Institute (Kansas City, MO), or synthesized as described previously (Lakshmi et al., 1990, 1996; Babu et al., 1995, 1996). N- and O-Glucuronides were prepared with human hepatic microsomes (Zenser et al., 1978), except for 3-hydroxy-benzidine and 3-hydroxy-N,N'-diacetylbenzidine, which used microsomes from beta -naphthoflavone-treated rats (Lakshmi et al., 1997). Glucuronides were radiolabeled with either 14C-UDP-glucuronic acid (279 mCi/mmol; ICN, Irvine, CA), or for benzidine and N-acetylbenzidine with 3H-benzidine (180 mCi/mmol; Chemsyn, Lenexa, KS; Babu et al., 1993, 1995). Incubation mixtures were extracted with ethyl acetate to remove the unreacted substrate and then with n-butanol to remove the glucuronide. The following radiochemical purity of the glucuronides was determined by HPLC: 77% benzidine, 93% N-acetylbenzidine, 84% N'-hydroxy-N-acetylbenzidine, 66% N-hydroxy-N-acetylbenzidine, 98% N-hydroxy-N,N'-diacetylbenzidine, 100% 3-hydroxy-N,N'diacetylbenzidine, 85% 3-hydroxy-benzidine, 55% 4-aminobiphenyl, 95% N-hydroxy-4-aminobiphenyl, and 98% N-hydroxy-N-acetyl-4-aminobiphenyl. The major impurity was the starting material, either 14C-UDP-glucuronic acid or 3H-aglycone. Glucuronides were identified by hydrolysis to their aglycone by treatment with acid or beta -glucuronidase as described previously (Babu et al., 1995, 1996). All of the aromatic amine substrates used in this study have been incubated with liver microsomes and shown to yield a single N- or O-glucuronide product that was rigorously characterized (Babu et al., 1992, 1993, 1995; Ciotti et al., 1999). Diglucuronide conjugates were not detected.

beta -Glucuronidase type VII-A from E. coli (11.3 Fishman U/µg) was obtained from Sigma Chemical Co. (St. Louis, MO) and exhibited 4,800 units of activity per µg at pH 7.0, using standardized conditions with 4-methylumbelliferyl beta -glucuronide as substrate (Watanabe et al., 1990). Pure human recombinant beta -glucuronidase was prepared as described previously (Watanabe et al., 1990) and exhibited 5,000 U/µg at pH 4.8 with 4-methylumbelliferyl beta -glucuronide as substrate. With 4-methylumbelliferyl beta -glucuronide, human beta -glucuronidase activity at pH 5.5 and 7.0 is 66 and 17%, respectively, of that at pH 4.8. E. coli beta -glucuronidase activity at pH 5.5 is 84% of that seen at pH 7.0.

To assess beta -glucuronidase hydrolysis of the aromatic amine N- or O-glucuronides, the glucuronides (6-12 µM) were dissolved in 100 mM phosphate buffer at pH 5.5 or 7.0 and incubated in a total volume of 0.025 ml for 30 min at 37°C with the indicated amount of beta -glucuronidase (Table 1). Sufficient enzyme was added to achieve partial hydrolysis of the N-hydroxy-N,N'-diacetylbenzidine O-glucuronide. Incubations were stopped by adding 0.025 ml of methanol and adjusting the pH to 9.0 with 1 N NaOH. Samples were immediately frozen at -70°C for analysis by HPLC.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Human and E. coli beta -glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl and their hydroxy metabolites at pH 5.5 and 7.0 

Glucuronides (6-12 µM) were incubated in 0.025 ml at 37°C for 30 min. Human beta -glucuronidase was used at 822 and 5,480 U at pH 5.5 and 7.0, respectively. E. coli beta -glucuronidase was used at 85 and 21 U at pH 5.5 and 7.0, respectively. Values represent the average of duplicate determinations from a single experiment or the mean ± S.E.M. of two or more experiments.

Hydrolysis was assessed with a Beckman HPLC using System Gold software and consisted of a 5 µm, 4.6 × 150 mm C-18 ultrasphere column attached to a guard column (RP-18, 7 µm 15 × 3.2 mm; Brownlee Columns, Perkin Elmer, Norwalk, CT). The solvent system contained 5% methanol in 20 mM phosphate buffer (pH 7.0), 0 to 5 min; 5 to 80%, 5 to 17 min; 80 to 5%, 20 to 25 min; flow rate 1 ml/min. Radioactivity in HPLC eluents was measured using a FLO-ONE radioactive flow detector (Packard Instrument Company, Downers Grove, IL). Blanks were incubated without enzyme for 30 min. For all 10 glucuronides examined, the recovery of total radioactivity in the enzyme-treated samples was at least 90% that observed in the nontreated samples. To calculate the amount of product formed by beta -glucuronidase, the percentage of substrate hydrolyzed by enzyme was subtracted from the values observed in the blank and multiplied by the picomoles of substrate added.


    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Incubation conditions for human and E. coli beta -glucuronidase were optimized using N-hydroxy-N,N'-diacetylbenzidine O-glucuronide as substrate. The concentration-dependent metabolism of this O-glucuronide was assessed for human beta -glucuronidase at pH 7.0 in Fig. 1. Metabolism was concentration-dependent from 0 to 7,000 U of enzyme activity. The loss of substrate correlated with the recovery of product. When the concentration of N-hydroxy-N,N'-diacetylbenzidine O-glucuronide was increased from 12 to 24 µM with 5,500 U of enzyme activity, nearly twice the amount of hydrolysis was observed. This suggests that human beta -glucuronidase is not saturated at this substrate concentration. Similar results were observed with the E. coli enzyme. Both enzymes have different pH optimums. This is illustrated in Fig. 2. Although the human enzyme has higher activity at pH 5.5, the bacterial enzyme has higher activity at pH 7.0. Subsequent incubations were at either pH 5.5 or 7.0 and contained enzyme sufficient to achieve partial metabolism of N-hydroxy-N,N'-diacetylbenzidine O-glucuronide. In addition, neither 0.01 mM N-acetylbenzidine nor UDP-glucuronic acid altered hydrolysis of this O-glucuronide.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Concentration-dependent hydrolysis of N-hydroxy-N,N'-diacetylbenzidine O-glucuronide by human beta -glucuronidase.

The indicated units of enzyme activity were incubated with 12 µM O-glucuronide at pH 7.0 for 30 min and analyzed by HPLC as described in Materials and Methods.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of pH on hydrolysis of N-hydroxy-N,N'-diacetylbenzidine O-glucuronide by human and E. coli beta -glucuronidase.

O-Glucuronide (12 µM) was incubated with 1,000 and 21 units of human and E. coli enzyme, respectively, and analyzed by HPLC as described in Materials and Methods.

Human beta -glucuronidase demonstrated selective metabolism of N- and O-glucuronides of benzidine and 4-aminobiphenyl (Table 1). At the acidic pH, near its pH optimum, only the O-glucuronides were analyzed because the N-glucuronides are acid labile (Babu et al., 1993, 1995, 1996). Using the same amount of enzyme, glucuronide conjugates of the hydroxamic acids, N-hydroxy-N-acetylbenzidine, N-hydroxy-N,N'-diacetylbenzidine, and N-hydroxy-N-acetyl-4-aminobiphenyl, were metabolized to a similar extent. Considerably more metabolism was observed with the ring oxidation products, 3-hydroxy-benzidine and 3-hydroxy-N,N'-diacetylbenzidine. This preference for metabolism of O-glucuronides on the ring compared to the nitrogen was also observed at pH 7.0. No hydrolysis of any of the primary amine N-glucuronides, benzidine, N-acetylbenzidine, and 4-aminobiphenyl, was observed at pH 7.0. In contrast, considerable metabolism of the N-glucuronides of the N-hydroxyarylamines, N'-hydroxy-N-acetylbenzidine and N-hydroxy-4-aminobiphenyl, were observed. A large range of hydrolysis was observed for N- and O-glucuronides of benzidine and 4-aminobiphenyl metabolites at pH 7.0.

Selective metabolism of these N- and O-glucuronides was also observed with E. coli beta -glucuronidase (Table 1). Because the bacterial enzyme more efficiently metabolized O-glucuronides than the human enzyme, fewer units of enzyme were required to achieve significant hydrolysis. At pH 7.0, the highest rates of hydrolysis were observed for the hydroxamic acids with little or no metabolism observed with the ring hydroxy products. Although this preference for metabolism of O-glucuronides on the nitrogen compared to the ring was also observed at pH 5.5, considerable more metabolism of ring hydroxy products was observed at pH 5.5. Saccharic acid-1,4-lactone (0.5 mM), a specific inhibitor of beta -glucuronidase, caused complete inhibition of metabolism by both the bacterial and human enzymes. At pH 7.0, the bacterial enzyme exhibited little or no hydrolysis for N-glucuronides of both primary and N-hydroxyarylamines. If the amount of bacterial enzyme was increased 100-fold, significant metabolism of benzidine, N-acetylbenzidine, and 4-aminobiphenyl N-glucuronides was observed. Overall, at the concentrations used in Table 1, E. coli beta -glucuronidase hydrolyzed fewer substrates than the human enzyme at neutral pH.

To demonstrate the selectivity of beta -glucuronidase metabolism, 40 U of E. coli enzyme were added to an incubation at pH 7.0 that contained 12 µM the N-glucuronide of N-acetylbenzidine and 12 µM the O-glucuronide of N-hydroxy-N-acetyl-4-aminobiphenyl. In this combined incubation, nearly complete hydrolysis of the O-glucuronide (95%), but no hydrolysis of the N-glucuronide, was detected. Similar results were also observed with human beta -glucuronidase. This also demonstrates that the lack of hydrolysis of N-glucuronides is not due to the presence of nonradioactive substances, which are interfering with metabolism.


    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

These experiments have demonstrated selective hydrolysis of N- and O-glucuronides of benzidine and 4-aminobiphenyl and their hydroxy metabolites by both human and E. coli beta -glucuronidases. Both enzymes preferentially hydrolyzed O-glucuronides over N-glucuronides and distinguished between the structural isomers N-hydroxy-N,N'-diacetylbenzidine and 3-hydroxy-N,N'-diacetylbenzidine, and N'-hydroxy-N-acetylbenzidine and N-hydroxy-N-acetylbenzidine. The human enzyme distinguished between N-glucuronides of primary compared to N-hydroxyarylamines. This enzyme also preferred hydrolyzing ring O-glucuronides. In contrast, the bacterial enzyme demonstrated little metabolism of N-glucuronides and preferred O-glucuronides of hydroxamic acids. Thus, the selectivity for metabolizing these glucuronides is quite different for human and E. coli beta -glucuronidases.

Purity of the N-glucuronides did not contribute to their lack of metabolism by beta -glucuronidases. N-Acetylbenzidine N'-glucuronide and 4-aminobiphenyl N-glucuronide are 93 and 55% pure, respectively, but neither is hydrolyzed by beta -glucuronidase. The N-glucuronide of N-hydroxy-4-aminobiphenyl is 95% pure and is actively hydrolyzed by human, but not E. coli, beta -glucuronidase. In addition, neither 0.01 mM N-acetylbenzidine nor UDP-glucuronic acid altered hydrolysis of the O-glucuronide of N-hydroxy-N,N'-diacetylbenzidine. The combination experiment assessing O-glucuronide hydrolysis in the presence of N-acetylbenzidine N'-glucuronide further demonstrates that nonradioactive substances are not interfering and that N-glucuronides are not false substrates inhibiting hydrolysis in this manner. Thus, the results are consistent with N-glucuronides not being substrates for beta -glucuronidases.

The concentrations of human beta -glucuronidase used in these experiments are 140 to over 5000 times more than the normal range reported for this enzyme in urine (Glaser and Sly, 1973). Even under pathological conditions of the urinary tract, such as bladder cancer, which causes a 30% increase in urinary beta -glucuronidase activity (Paigen et al., 1984), the concentration of enzyme does not reach values required for metabolism. In contrast, E. coli beta -glucuronidase may metabolize O-glucuronides of these hydroxamic acids in urine at neutral pH (Harris et al., 1978). The bacterial enzyme would not be expected to hydrolyze N-glucuronides in urine at neutral pH. To allow comparison of beta -glucuronidase from the pure human and commercial bacterial preparation, both were assayed using 4-methylumbelliferyl beta -glucuronide as substrate under standard conditions, and corresponding units were used to express activity (Watanabe et al., 1990). The results suggest that the bacterial enzyme may be much more efficient in hydrolyzing hydroxamic acid O-glucuronides than the human enzyme.

Although the N-glucuronides are poor substrates for beta -glucuronidase, these conjugates are quite acid-labile. For the N-glucuronides of benzidine, N-acetylbenzidine, 4-aminobiphenyl, and N-hydroxy-4-aminobiphenyl, their T1/2 values at pH 5.5 range from 5 to 30 min (Babu et al., 1993, 1995, 1996). In contrast, the T1/2 values at pH 7.4 extend from 100 to over 200 min for the same N-glucuronides (Babu et al., 1993, 1995, 1996). This acid lability has been proposed to contribute to the carcinogenic process by causing N-glucuronides to be hydrolyzed to their parent amines in acidic urine and by accumulation of the amines in the bladder epithelium. Amines are then activated to form DNA adducts, which initiate carcinogenesis. This hypothesis is supported by recent experiments evaluating benzidine and N-acetylbenzidine metabolism in workers exposed to benzidine. In postworkshift urine, pH was inversely correlated with the proportions of benzidine and N-acetylbenzidine present as free compounds (Rothman et al., 1997). When controlling for internal dose, individuals with urine pH < 6 had a 10-fold higher DNA adduct level, N'-(3'-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine, in their exfoliated bladder cells compared with subjects with urine pH >=  7. This DNA adduct produces genotoxic lesions, causing mutations in various bacterial and mammalian test systems in vitro (Beland et al., 1983; Heflich et al., 1986; Melchior Jr et al., 1994) and mutations in oncogenes of tumors induced in vivo by benzidine (Fox et al., 1990). Thus, although selective hydrolysis of N- and O-glucuronides was demonstrated by both human and E. coli beta -glucuronidases, neither enzyme efficiently metabolized N-glucuronides at neutral pH. These results suggest that nonenzymatic hydrolysis of N-glucuronides by acidic urine is an important source of free amine in the bladder lumen of exposed workers.

    Acknowledgments

We thank Dr. William S. Sly and Jeffrey H. Grubb for the pure human beta -glucuronidase, advice on analysis of beta -glucuronidase activity, and for critically reviewing the manuscript. We also thank Cindee Rettke and Priscilla DeHaven for excellent technical assistance.

    Footnotes

Received February 9, 1999; accepted April 29, 1999.

This work was supported by the Department of Veterans Affairs (T.V.Z., B.B.D.) and National Cancer Institute Grant CA72613 (T.V.Z.).

Send reprint requests to: Terry V. Zenser, Ph.D., Veterans Administration Medical Center (11G-JB), St. Louis, MO 63125-4199. E-mail: zensertv{at}slu.edu

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0090-9556/99/2709-1064-1067$02.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. K. Froehlich, U. Girreser, and B. Clement
METABOLISM OF N-HYDROXYGUANIDINES (N-HYDROXYDEBRISOQUINE) IN HUMAN AND PORCINE HEPATOCYTES: REDUCTION AND FORMATION OF GLUCURONIDES
Drug Metab. Dispos., October 1, 2005; 33(10): 1532 - 1537.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Z. Berry, P. Borgeat, J. Gosselin, L. Flamand, and R. C. Murphy
Urinary Metabolites of Leukotriene B4 in the Human Subject
J. Biol. Chem., June 27, 2003; 278(27): 24449 - 24460.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zenser, T. V.
Right arrow Articles by Davis, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zenser, T. V.
Right arrow Articles by Davis, B. B.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition